Specialty societies set new policy on drug company influence

My lede:

Under scrutiny from politicians and physician critics, some medical specialty societies are pledging to disclose the industry funding they receive and say what that money pays for.

The promise comes as part of a code approved in April by the Council of Medical Specialty Societies, whose member organizations together represent more than 650,000 American physicians. The pressure on physician organizations to tell the public about industry support and limit the companies’ influence on their educational, research and advocacy activities has been building over the last year.

The whole shebang.